Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Soy Lecithin-derived N-oleoyl-phosphatidyl-ethanolamine (NOPE) and Green Tea-derived Epigallocatechin Gallate (EGCG) on Indices of Weight Loss and Appetite Suppression

NCT00153790 is registered in ClinicalTrials.gov with The Cooper Institute as lead sponsor.

NCT NCT00153790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00153790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Soy Lecithin-derived N-oleoyl-phosphatidyl-ethanolamine (NOPE) and Green Tea-derived Epigallocatechin Gallate (EGCG) on Indices of Weight Loss and Appetite Suppression
Lead sponsor
The Cooper Institute
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2005
Completion date
May 31, 2006
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

weight loss